Rabbit anti-UACA Antibody Affinity Purified
Catalog #
UACA
Human
,Mouse
,Rat
IP
,WB
Rabbit
Polyclonal
Whole IgG
Between 1100 and 1150
IgG
Unconjugated
Antigen Affinity Purified
Product Details
Rat,
Mouse,
Human
Human
2 - 8 °C
1 year from date of receipt
Antibody was affinity purified using an epitope specific to UACA immobilized on solid support.
The epitope recognized by A301-383A maps to a region between residue 1075 and 1125 of human uveal autoantigen with coiled-coil domains and ankyrin repeats using the numbering given in entry NP_060473.2 (GeneID 55075).
Immunoglobulin concentration was determined using Beer’s Law where 1mg/mL IgG has an A280 of 1.4.
Antibody was affinity purified using an epitope specific to UACA immobilized on solid support.
The epitope recognized by A301-383A-T maps to a region between residue 1075 and 1125 of human uveal autoantigen with coiled-coil domains and ankyrin repeats using the numbering given in entry NP_060473.2 (GeneID 55075).
UACA (uveal autoantigen with coiled-coil domains and ankyrin repeats) was originally identified as an autoantigen in patients with panuveitis, a characteristic of Vogt-Koyanagi-Harada disease, and in patients with Graves’ disease. UACA was also later identified as Nucling, an mRNA differentially expressed in F9 embryonal carcinoma cells during cardiac muscle differentiation. UACA appears to function as a pro-apoptotic protein that recruits the apaf-1-pro-caspase-9 complex for the induction of apoptosis to mediate the cell-death pathway.
Uveal autoantigen with coiled-coil domains and ankyrin repeats
Alternate Names
nuclear membrane binding protein; NUCLING; uveal autoantigen with coiled-coil domains and ankyrin repeats
Applications